Isoliquiritigenin suppresses human T Lymphocyte activation via covalently binding cysteine 46 of IκB kinase

The efficacious practice of precision personalized medicine requires a more exact understanding of the molecular mechanisms of drug, hence then it is necessary to identify the binding site of the drugs derived from natural sources. In the study, we investigated the suppressive effect and underlying...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Fenggen, Yang, Fen, Wang, Rui, Yao, Xiao Jun, Bai, Liping, Zeng, Xing, Huang, JiaJun, Wong, Vincent Kam Wai, Lam, Christopher Wai Kei, Zhou, Hua, Su, Xiaohui, Liu, Juan, Li, Ting, Liu, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470962/
https://www.ncbi.nlm.nih.gov/pubmed/27626700
http://dx.doi.org/10.18632/oncotarget.11934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470962/
https://www.ncbi.nlm.nih.gov/pubmed/27626700
http://dx.doi.org/10.18632/oncotarget.11934

Ejemplares similares